CureVac
| Use attributes for filter ! | |
| Headquarters location | Tübingen, Germany |
|---|---|
| Founders | Ingmar Hoerr |
| Founded | 2000 |
| Number of employees | 400 (approximate) |
| CFO | Pierre Kemula |
| Subsidiary | CureVac Inc. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2349901 |
About CureVac
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA. The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases.
